General Practice Doctors in Bay City, MI Accepting Medicare

5 General Practice doctors found. Showing 1 - 5

Hany S Zekry, DO General Practice Medicare: Medicare Enrolled Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 989-894-3950    Fax: 989-894-6126

Joseph Vincent Zarrillo, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 1484 Straits Dr Ste 5, Bay City, MI 48706 Phone: 989-667-8740

Ivette Margarita Zarrillo, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1484 Straits Dr Ste 5, Bay City, MI 48706 Phone: 989-667-8740

Dr. Erik Paul Voogd, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 4121 Shrestha Dr, Bay City, MI 48706 Phone: 989-686-6900    Fax: 989-686-6911

April R St John-keenoy, DO General Practice Medicare: Medicare Enrolled Practice Location: 1484 Straits Dr Ste 5, Bay City, MI 48706 Phone: 989-667-8740    Fax: 989-667-8745

News Archive

Abortion, other issues continue to stoke the politics surrounding health reform

Politico reports that "the issues of health care and abortion" are making the campaign tough for some Democrats. Among the vulnerable Democrats are Reps. Kathleen Dahlkemper, D-Pa.; Steve Driehaus, D-Ohio; and Indiana Reps. Joe Donnelly and Brad Ellsworth, who is running for Senate. "'We are going to do everything we can to point out that Democrats who said they were pro-life caved on the big one,' said Marilyn Musgrave, a former Colorado congresswoman.

Nervous system plays vital role in age-related weakness, study finds

A study recently published by researchers from the Ohio Musculoskeletal and Neurological Institute at the Ohio University Heritage College of Osteopathic Medicine, in collaboration with a colleague from outside Ohio University, finds new evidence to support the belief that the nervous system plays an important role in age-related weakness.

Gilead Sciences signs definitive agreement to acquire CGI Pharmaceuticals

Gilead Sciences, Inc. and CGI Pharmaceuticals, Inc., a privately-held, development-stage pharmaceutical company focused on small molecule chemistry and kinase biology, today announced the signing of a definitive agreement pursuant to which Gilead will acquire CGI. Under the terms of the agreement, Gilead will acquire CGI for up to $120 million, the majority as an upfront payment and the remaining based on clinical development progress, all of which will be financed through available cash on hand.

New lab-based approach shows how microbes can work with hosts to prevent infection

The benefits of antibiotics to both human and animal health are undisputed. However, as microbes have become increasingly resistant to antimicrobials and other drugs, scientists have become interested in new solutions to the growing superbug crisis, including the use of defensive microbes and faecal transplants.

Read more Medical News

› Verified 3 days ago